NASDAQ: LPCN $110 Million Small-Cap. Health Care Sector. Drug Manufacturers Industry. 5 Year Return 78%. 1 Year Return 291%. 2021 YTD Return 45%. Since Earnings 45%.
The 52 Week Low is $0.32 set on Mon, Mar 16, 2020.
The 52 Week High is $2.39 set on Mon, Aug 17, 2020.
The All-Time High is $20.00 set on Wed, Aug 28, 2013.
Earnings Per Share
Price To Earnings Ratio
Dividend Yield
Dividend Rate
Ex-Dividend Date
Dividend Payment Date
Dividend Frequency
Dividend History
Lipocine Inc trades on the NASDAQ. LPCN's market cap is 110.00 Million.
Lipocine Inc is a clinical-stage biopharmaceutical company. It is focused on oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. The company's product TLANDO, is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, LPCN 1148 and LPCN 1107.
For Starters
Track your portfolio and more.
